Charney D I, Walton D F, Cheung A K
University of Utah, Salt Lake City.
Curr Opin Nephrol Hypertens. 1993 Nov;2(6):876-82. doi: 10.1097/00041552-199311000-00004.
Atherosclerotic cardiovascular disease is a significant cause of morbidity and mortality in patients with chronic renal failure. It is unclear, however, if atherosclerosis in fact occurs at a higher incidence compared with the nonuremic population matched for age, hypertension, and diabetes mellitus or if it occurs at an accelerated rate following the onset of end-stage renal disease. The extent of true atherosclerotic lesions, versus clinically diagnosed "atherosclerosis," in patients with chronic renal failure is equally unclear. Potentially, the uremic state per se, the dialysis treatment, and factors unrelated to renal failure may participate in atherogenesis. The relative contribution of each of these factors is unknown. In this review, we discuss the pathology of "atherosclerotic" lesions in patients with chronic renal failure and the putative factors involved in atherogenesis in this population and describe the results of available studies examining the issue of accelerated atherosclerosis in uremia.
动脉粥样硬化性心血管疾病是慢性肾衰竭患者发病和死亡的重要原因。然而,与年龄、高血压和糖尿病相匹配的非尿毒症人群相比,动脉粥样硬化的实际发病率是否更高,或者在终末期肾病发病后是否以加速的速度发生,目前尚不清楚。慢性肾衰竭患者真正的动脉粥样硬化病变程度与临床诊断的“动脉粥样硬化”程度同样不明确。潜在地,尿毒症状态本身、透析治疗以及与肾衰竭无关的因素可能参与动脉粥样硬化的形成。这些因素各自的相对贡献尚不清楚。在本综述中,我们讨论了慢性肾衰竭患者“动脉粥样硬化”病变的病理学以及该人群中动脉粥样硬化形成的假定因素,并描述了现有研究关于尿毒症中加速动脉粥样硬化问题的研究结果。